Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
J Clin Psychiatry 77(11):e1439e1446 Back SE, Gray K, Santa Ana E, Jones JL, Jarnecke AM, Joseph JE et al (2020) N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: design and methodology of a randomized clinical trial
Meanwhile, in the UK, the MHRA authorized Tzield as the first immunotherapy for T1D, marking a paradigm shift for patients who have historically relied solely on insulin
Visual Style: Editorial evidence chart with neutral icons, clear hierarchy, and restrained colors
Psychiatry 23 , 392399 (2018)
86(9): p
:format(webp))
US$ 28.57
US$ 27.91
US$ 25.82
US$ 23.22
